TriSalus Life Sciences (TLSI) Other Non-Current Liabilities (2020 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Other Non-Current Liabilities of $2.7 million for Q1 2026, down 71.01% year-over-year from $9.5 million in Q1 2025, and down 72.97% quarter-over-quarter from $10.1 million in Q4 2025.
TriSalus Life Sciences (TLSI) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
TriSalus Life Sciences' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 71.01% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (down 71.01% YoY), while the FY2025 annual figure was $10.1 million, up 21.98% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $2.7 million, down from $10.1 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $18.6 million in Q4 2023, with the low at $369000.0 in Q4 2022.
- The 5-year median for Other Non-Current Liabilities is $5.4 million (2023), against an average of $6.2 million.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities slumped 94.65% in 2022, then soared 4949.32% in 2023.
- TriSalus Life Sciences' Other Non-Current Liabilities stood at $369000.0 in 2022, then jumped by 4949.32% to $18.6 million in 2023, then sank by 55.37% to $8.3 million in 2024, then grew by 21.98% to $10.1 million in 2025, then slumped by 72.97% to $2.7 million in 2026.
- Business Quant data shows TLSI's Other Non-Current Liabilities at $2.7 million in Q1 2026, $10.1 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.32 Mn |
| Mar 31, 2026 | 2.74 Mn |
| Dec 31, 2025 | 10.14 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 7.50 Mn |
| Mar 31, 2025 | 9.46 Mn |
| Dec 31, 2024 | 8.32 Mn |
| Sep 30, 2024 | 7.81 Mn |
| Jun 30, 2024 | 8.93 Mn |
| Mar 31, 2024 | 14.58 Mn |
| Dec 31, 2023 | 18.63 Mn |
| Sep 30, 2023 | 5.42 Mn |
| Jun 30, 2023 | 530,666.00 |
| Mar 31, 2023 | 796,000.00 |
| Dec 31, 2022 | 369,000.00 |
| Sep 30, 2022 | 796,000.00 |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Dec 31, 2021 | 6.90 Mn |
| Sep 30, 2021 | 10.93 Mn |